Published in Int J Stroke on January 12, 2015
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet (2013) 12.44
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace (2013) 5.16
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol (2010) 3.26
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke (2013) 2.52
Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol (2014) 2.30
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost (2014) 2.29
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol (2012) 1.99
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J (2014) 1.30
Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost (2014) 1.13
Anticoagulation intensity of rivaroxaban for stroke patients at a special low dosage in Japan. PLoS One (2014) 0.86
Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation. J Neurol Sci (2013) 0.80
Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain. J Cereb Blood Flow Metab (2002) 1.03
Cerebral small vessel disease and chronic kidney disease. J Stroke (2015) 0.89
Early-onset dystonia after supplementary motor area infarction. J Stroke Cerebrovasc Dis (2014) 0.81
Epidemiology and registry studies of stroke in Japan. J Stroke (2013) 0.81
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy without anterior temporal pole involvement: a case report. J Stroke Cerebrovasc Dis (2013) 0.81
Factors Associated with Early Hospital Arrival in Patients with Acute Ischemic Stroke. J Stroke (2015) 0.78
Reperfusion enhances nitrotyrosine formation in rat focal cerebral ischemia. J Stroke Cerebrovasc Dis (2007) 0.77
Early Stroke Risk after Transient Ischemic Attack in Patients without Large-Artery Disease or Atrial Fibrillation. J Stroke Cerebrovasc Dis (2015) 0.76
Blood glucose levels during the initial 72 h and 3-month functional outcomes in acute intracerebral hemorrhage: the SAMURAI-ICH study. J Neurol Sci (2015) 0.76
Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms. Am J Obstet Gynecol (2016) 0.76
Response to Letter Regarding Article, "Acute Reperfusion Therapy and Stroke Care in Asia After Successful Endovascular Trials". Stroke (2015) 0.75
Percutaneous Transluminal Angioplasty Improved Posterior Reversible Encephalopathy Syndrome due to Renovascular Hypertension. J Stroke Cerebrovasc Dis (2015) 0.75
Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial. J Stroke Cerebrovasc Dis (2015) 0.75
Stroke education using an animated cartoon and a manga for junior high school students. J Stroke Cerebrovasc Dis (2014) 0.75
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke (2016) 0.75
Development of Interstitial Lung Disease after Initiation of Apixaban Anticoagulation Therapy. J Stroke Cerebrovasc Dis (2016) 0.75
Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation. Stroke (2016) 0.75
Ipsilateral hemiparesis in lateral medullary infarction: Clinical investigation of the lesion location on magnetic resonance imaging. J Neurol Sci (2016) 0.75
What are the next breakthroughs in the management of acute intracerebral hemorrhage? Int J Stroke (2016) 0.75
Slowly progressive Lemierre's syndrome with orbital pain and exophthalmos. J Infect Chemother (2015) 0.75
Novel brain computed tomography perfusion for cerebral malperfusion secondary to acute type A aortic dissection. Interact Cardiovasc Thorac Surg (2022) 0.75
Risk factors for post-stroke seizure recurrence after the first episode. Seizure (2017) 0.75
The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol. J Stroke Cerebrovasc Dis (2016) 0.75
Optimal Peak Systolic Velocity Thresholds for Predicting Internal Carotid Artery Stenosis Greater than or Equal to 50%, 60%, 70%, and 80. J Stroke Cerebrovasc Dis (2016) 0.75
Neurologic improvement without angiographic improvement after antithyroid therapy in a patient with Moyamoya syndrome. J Stroke Cerebrovasc Dis (2013) 0.75